Table 3.

Drug consumption features and their relationship to colonic preparation in the studied population

		BBPS score
		Adequate 1688 (68.2)	Inadequate 788 (31.8)	OR (95% CI)*	P-value
ASA	No	1415 (85.3)	626 (81.4)
	Yes	243 (14.7)	143 (18.6)	1.33 (1.06- 1.67)	0.014
NSAID	No	1565 (94.6)	744 (97.5)
	Yes	89 (5.4)	19 (2.5)	0.45 (0.27- 0.74)	0.002
Anti-TNF	No	1638 (99.0)	755 (98.8)
	Yes	16 (1.0)	9 (1.2)	1.22 (0.54- 2.77)	0.635
Prednisolone	No	1637 (99.0)	756 (99.0)
	Yes	17 (1.0)	8 (1.0)	1.02 (0.44- 2.37)	0.965
Azathioprine	No	1628 (98.4)	756 (99.0)
	Yes	26 (1.6)	8 (1.0)	0.66 (0.30- 1.47)	0.312
TCA	No	1646 (99.5)	760 (99.5)
	Yes	8 (0.5)	4 (0.5)	1.08 (0.32- 3.61)	0.897
SSRI	No	1568 (94.8)	746 (97.5)
	Yes	86 (5.2)	19 (2.5)	0.46 (0.28- 0.77)	0.003
PPI	No	1405 (84.7)	675 (88.5)
	Yes	254 (15.3)	88 (11.5)	0.72 (0.56- 0.93)	0.013
Gliclazide	No	1645 (99.5)	750 (98.0)
	Yes	9 (0.5)	15 (2.0)	3.66 (1.59- 8.39)	0.002
Insulin	No	1629 (98.4)	738 (96.5)
	Yes	26 (1.6)	27 (3.5)	2.29 (1.33- 3.95)	0.003
Glibenclamide	No	1628 (98.4)	748 (97.8)
	Yes	26 (1.6)	17 (2.2)	1.42 (0.77- 2.64)	0.263
Metformin	No	1541 (93.2)	687 (89.9)
	Yes	113 (6.8)	77 (10.1)	1.53 (1.13- 2.07)	0.006
Ferrous Sulfate	No	1627 (98.2)	753 (98.6)
	Yes	30 (1.8)	11 (1.4)	0.79 (0.39- 1.59)	0.512
Statin	No	1422 (85.9)	674 (87.3)
	Yes	234 (14.1)	98 (12.7)	0.85 (0.66- 1.10)	0.222
ACE-I Or ARB	No	1389 (83.8)	601 (79.0)
	Yes	269 (16.2)	160 (21.0)	1.37 (1.11- 1.71)	0.004
GnRH	No	1643 (99.3)	749 (97.9)
	Yes	11 (0.7)	16 (2.1)	3.19 (1.47- 6.91)	0.003
Vitamin D3	No	1316 (79.4)	645 (84.8)
	Yes	341 (20.6)	116 (15.2)	0.69 (0.55- 0.87)	0.002
Calcium	No	1361 (82.1)	654 (85.9)
	Yes	296 (17.9)	107 (14.1)	0.72 (0.59- 0.96)	0.020

* OR is reported for inadequate groups compared with adequate groups as reference group